開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
美聯儲威廉姆斯:不認爲穩定幣會帶來金融穩定性風險上升。
2026-07-09
美聯儲威廉姆斯:不認爲穩定幣會帶來金融穩定性風險上升。
返回
其他消息
2026-07-09
Per Fujian’s flood, drought and typhoon emergency plan, the provincial flood-control command activated a Level IV typhoon emergency response at 09:00 on July 9. The provincial command and the provincial emergency management department ordered coastal localities and relevant departments to closely monitor Typhoon Bavi, be ready to activate emergency measures, strengthen command and hazard inspections, organise timely evacuations and implement defensive measures.
Per Fujian’s flood, drought and typhoon emergency plan, the provincial flood-control command activated a Level IV typhoon emergency response at 09:00 on July 9. The provincial command and the provincial emergency management department ordered coastal localities and relevant departments to closely monitor Typhoon Bavi, be ready to activate emergency measures, strengthen command and hazard inspections, organise timely evacuations and implement defensive measures.
2026-07-09
Sinopharm Group Co. (01099.HK) and Merck (China) (MRK.N) met in Shanghai to discuss the potential appointment of Sinopharm as exclusive import/distribution agent for innovative drug Xinrulai® and related post-launch cooperation. The parties agreed to deepen strategic collaboration to improve access to rare-disease therapies and commercialization efficiency in China.
Sinopharm Group Co. (01099.HK) and Merck (China) (MRK.N) met in Shanghai to discuss the potential appointment of Sinopharm as exclusive import/distribution agent for innovative drug Xinrulai® and related post-launch cooperation. The parties agreed to deepen strategic collaboration to improve access to rare-disease therapies and commercialization efficiency in China.
Chat with us
, powered by
LiveChat